Hofseth BioCare ASA (OSL: HBC)
Norway
· Delayed Price · Currency is NOK 1.300
-0.040 (-2.99%)
Nov 21, 2024, 4:25 PM CET
Hofseth BioCare ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -133.48 | -106.68 | -137.39 | -126.46 | -102.09 | -89.21 | Upgrade
|
| Depreciation & Amortization | 32.06 | 29.87 | 24.41 | 25.72 | 23.36 | 25.15 | Upgrade
|
| Other Amortization | 6.54 | 6.54 | 5.81 | 3.63 | 3.41 | 2.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -8.06 | -23.49 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.19 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 2.54 | 2.54 | -0.2 | -0.03 | 0.78 | - | Upgrade
|
| Other Operating Activities | 13.42 | 9.49 | 9.95 | 9.39 | 8.66 | 8.06 | Upgrade
|
| Change in Accounts Receivable | -12.5 | -0.78 | -3.98 | 4.18 | -8.73 | 9.16 | Upgrade
|
| Change in Inventory | 38.26 | 33.98 | -25.71 | -17.51 | -39.32 | -4.58 | Upgrade
|
| Change in Accounts Payable | -134.49 | -90.59 | 70.36 | 39.21 | 55.25 | -2.4 | Upgrade
|
| Change in Other Net Operating Assets | 136.33 | 141.87 | 11.4 | 0.1 | -2.96 | 20.47 | Upgrade
|
| Operating Cash Flow | -59.38 | 2.76 | -45.17 | -61.78 | -61.63 | -31.06 | Upgrade
|
| Capital Expenditures | -0.23 | -8.19 | -4.02 | -22.92 | -32.58 | -10.28 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.36 | -5.87 | -13.76 | -14.83 | -21.88 | -9.78 | Upgrade
|
| Investment in Securities | -1.62 | -1.62 | - | -0.19 | -5.6 | 0.45 | Upgrade
|
| Other Investing Activities | 0.69 | 0.69 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -2.51 | -14.99 | -17.78 | -37.94 | -60.06 | -19.6 | Upgrade
|
| Long-Term Debt Issued | - | 28.35 | - | 1.09 | 39.02 | 21.61 | Upgrade
|
| Long-Term Debt Repaid | - | -14.18 | -15.05 | -14.89 | -70.64 | -22.06 | Upgrade
|
| Net Debt Issued (Repaid) | 82.3 | 14.17 | -15.05 | -13.8 | -31.62 | -0.46 | Upgrade
|
| Issuance of Common Stock | - | - | 70.78 | - | 245.65 | 108.94 | Upgrade
|
| Other Financing Activities | -14.7 | -10.48 | -10.28 | -9.39 | -14.06 | -11.9 | Upgrade
|
| Financing Cash Flow | 67.6 | 3.69 | 45.45 | -23.2 | 199.97 | 96.58 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | 5.71 | -8.54 | -17.49 | -122.91 | 78.28 | 45.91 | Upgrade
|
| Free Cash Flow | -59.61 | -5.43 | -49.19 | -84.7 | -94.21 | -41.34 | Upgrade
|
| Free Cash Flow Margin | -24.03% | -2.49% | -40.84% | -96.68% | -136.04% | -60.99% | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -0.01 | -0.13 | -0.24 | -0.28 | -0.13 | Upgrade
|
| Cash Interest Paid | 13.42 | 9.49 | 9.95 | 9.39 | 8.58 | 7.29 | Upgrade
|
| Levered Free Cash Flow | -157.67 | -100.88 | -72.21 | -65.15 | -94.57 | -39.29 | Upgrade
|
| Unlevered Free Cash Flow | -150.5 | -96.16 | -65.99 | -59.28 | -88.81 | -33.93 | Upgrade
|
| Change in Net Working Capital | 114.01 | 54.44 | 0.51 | -20.13 | 3.61 | -7.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.